Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Younis · SciRah

Researcher profile · Semantic Scholar

T. Younis

Share profile

T. Younis — researcher profile on SciRah

h-index: 21
Works: 110
Citations: 1,089

Most-cited papers

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
N. Lamond, C. Skedgel, D. Rayson, L. Lethbridge +1 more
2012Breast Cancer Research and Treatment57 citations
Semantic Scholar
Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.
D. Rayson, J. Payne, M. Abdolell, P. Barnes +5 more
2011Clinical Breast Cancer53 citations
Semantic Scholar
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
A. Jeyakumar, T. Younis
2012Clinical Medicine Insights: Oncology50 citations Open access
Semantic Scholar
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis
T. Younis, D. Rayson, K. Thompson
2012Supportive Care in Cancer48 citations
Semantic Scholar
The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada
A. Drucker, C. Skedgel, K. Virik, D. Rayson +2 more
2008Current Oncology44 citations Open access
Semantic Scholar
Wait times for breast cancer care
N. Saint-Jacques, T. Younis, R.A.D. Dewar, D. Rayson
2006British Journal of Cancer39 citations Open access
Semantic Scholar
Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC)
N. Saint-Jacques, D. Rayson, T. Al-fayea, K. Virik +2 more
2008Journal of Thoracic Oncology38 citations Open access
Semantic Scholar
The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial.
C. Skedgel, D. Rayson, T. Younis
2009Value in Health37 citations Open access
Semantic Scholar
Adjuvant Chemotherapy Uptake in Non-small Cell Lung Cancer
T. Younis, T. Al-fayea, K. Virik, W. Morzycki +1 more
2008Journal of Thoracic Oncology37 citations Open access
Semantic Scholar
The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer.
T. Younis, D. Rayson, C. Skedgel
2011Current Oncology32 citations Open access
Semantic Scholar
Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy.
N.W.D. Lamond, T. Younis, K. Purdy, M. Dorreen
2013Current Oncology31 citations Open access
Semantic Scholar
Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole
C. Skedgel, D. Rayson, R. Dewar, T. Younis
2007Breast Cancer Research and Treatment30 citations
Semantic Scholar
Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04
D. Rayson, N. Saint-Jacques, T. Younis, Jason Meadows +1 more
2007Canadian Medical Association Journal28 citations Open access
Semantic Scholar
Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.
C. Skedgel, D. Rayson, R. Dewar, T. Younis
2007Breast28 citations
Semantic Scholar
Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100
T. Younis, D. Rayson, M. Sellon, C. Skedgel
2008Breast Cancer Research and Treatment27 citations
Semantic Scholar
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects
H. Au, K. Golmohammadi, T. Younis, S. Verma +3 more
2009Breast Cancer Research and Treatment25 citations
Semantic Scholar
Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy.
A. Jeyakumar, Jillian C Dipenta, S. Snow, D. Rayson +3 more
2012Clinical Breast Cancer23 citations
Semantic Scholar
Length of Survival in Hospice for Cancer Patients Referred From a Comprehensive Cancer Center
T. Younis, R. Milch, N. Abul-Khoudoud, D. Lawrence +2 more
2009The American journal of hospice & palliative care23 citations
Semantic Scholar
Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray
K. Dakin-Hache, S. Gray, P. Barnes, R. Dewar +2 more
2007Breast Cancer Research and Treatment22 citations
Semantic Scholar
Length of Survival of Patients with Cancer in Hospice: A Retrospective Analysis of Patients Treated at a Major Cancer Center Versus Other Practice Settings
T. Younis, R. Milch, N. Abul-Khoudoud, D. Lawrence +2 more
2007Journal of Palliative Medicine21 citations
Semantic Scholar
Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer.
Caitlin Lees, S. Weerasinghe, N. Lamond, T. Younis +1 more
2019Current Oncology18 citations Open access
Semantic Scholar
Survivin and COX-2 expression in male breast carcinoma.
T. Younis, K. Dakin-Hache, D. Rayson, R. Dewar +2 more
2009Breast17 citations Open access
Semantic Scholar
Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
Arik Durcker, B. Yoo, I. Khan, Dongsic Choi +5 more
2020Breast Cancer Research16 citations Open access
Semantic Scholar
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer.
T. Younis, D. Rayson, R. Dewar, C. Skedgel
2006Annals of Oncology16 citations Open access
Semantic Scholar
Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?
N. Lamond, C. Skedgel, T. Younis
2013Expert review of pharmacoeconomics & outcomes research15 citations
Semantic Scholar
ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth
I. Khan, B. Yoo, M. McPhee, O. Masson +5 more
2018Breast Cancer Research14 citations Open access
Semantic Scholar
Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression‐Free Survival on First‐Line Therapy Predicts Overall Survival Impact
D. Rayson, S. Lutes, G. Walsh, M. Sellon +5 more
2014The Breast Journal14 citations
Semantic Scholar
Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?
C. Skedgel, D. Rayson, T. Younis
2013Annals of Oncology14 citations Open access
Semantic Scholar
EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol
M. Keats, S. Grandy, N. Giacomantonio, D. MacDonald +2 more
2016Pilot and Feasibility Studies13 citations Open access
Semantic Scholar
Is trastuzumab a cost-effective treatment for breast cancer?
T. Younis, C. Skedgel
2008Expert review of pharmacoeconomics & outcomes research13 citations
Semantic Scholar
Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
T. Younis, D. Rayson, S. Jovanović, C. Skedgel
2016Breast Cancer Research and Treatment12 citations Open access
Semantic Scholar
Nurse Navigators’ Views on Patient and System Factors Associated with Navigation Needs among Women with Breast Cancer
Sally Miller, R. Urquhart, G. Kephart, Y. Asada +1 more
2021Current Oncology11 citations Open access
Semantic Scholar
Economic evaluation of adjuvant trastuzumab emtansine in patients with HER2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab-based treatment in Canada.
T. Younis, A. Lee, M. Coombes, N. Bouganim +3 more
2020Current Oncology11 citations Open access
Semantic Scholar
The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis
P. O'Brien, K. Matheson, A. Jeyakumar, K. Anderson +1 more
2019Breast Cancer Research and Treatment11 citations
Semantic Scholar
Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study.
Daniel Rayson, S. Lutes, M. Sellon, B. Colwell +5 more
2012Current Oncology11 citations Open access
Semantic Scholar
Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
C. Skedgel, D. Rayson, T. Younis
2015Supportive Care in Cancer10 citations
Semantic Scholar
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
Alexi P. Surette, B. Yoo, T. Younis, K. Matheson +4 more
2021Breast Cancer Research and Treatment8 citations
Semantic Scholar
Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations
A. Groom, T. Younis
2016Expert review of pharmacoeconomics & outcomes research7 citations
Semantic Scholar
The cost burden of trastuzumab and bevacizumab monoclonal antibody therapy in solid tumors: Can we afford it?
A. Drucker, K. Virik, C. Skedgel, D. Rayson +2 more
2006Journal of Clinical Oncology7 citations
Semantic Scholar
Isolated metastasis to the cerebellopontine angle secondary to breast cancer.
Yien Chiong, L. Mulroy, I. Fleetwood, T. Younis
2009Canadian journal of surgery. Journal canadien de chirurgie6 citations
Semantic Scholar
Oncology education for internal medicine residents: a call for action!
T. Younis, B. Colwell
2018Current Oncology5 citations Open access
Semantic Scholar
The politicization of oncology drug funding reviews in Canada.
C. Skedgel, T. Younis
2016Current Oncology5 citations Open access
Semantic Scholar
Women's views about breast cancer prevention at mammography screening units and well women's clinics.
A. Rundle, S. Iles, K. Matheson, L. E. Cahill +4 more
2020Current Oncology4 citations Open access
Semantic Scholar
Timeliness of the oncology drug review process for public funding in Canada.
T. Younis, C. Skedgel
2017Current Oncology4 citations Open access
Semantic Scholar
Chemotherapy uptake and wait times in early-stage non-small-cell lung cancer.
Samantha Gray, J. Bu, N. Saint-Jacques, D. Rayson +1 more
2012Current Oncology4 citations Open access
Semantic Scholar
Economic evaluation of adjuvant chemotherapy in Stage III (SIII) colon cancer: Capecitabine versus 5FU/LV.
K. Virik, C. Skedgel, T. Younis
2006Journal of Clinical Oncology4 citations
Semantic Scholar
Adjuvant chemotherapy in breast cancer: is TC a cost-effective regimen compared to AC?.
T. Younis, D. Rayson, C. Skedgel
20093 citations
Semantic Scholar
Does Her2/neu status affect adjuvant chemotherapy utilization? A population based analysis
S. Snow, D. Rayson, P. Barnes, M. Sellon +2 more
20083 citations
Semantic Scholar
Accounting for improved outcomes in budget impact analyses: Adjuvant trastuzumab in HER2/neu-positive breast cancer
C. Skedgel, D. Rayson, T. Younis
20083 citations
Semantic Scholar
Exercise to Prevent Anthracycline-Based Cardiotoxicity (EXACT): A Feasibility Study
Stefan D. Heinze-Milne, M. Keats, C. Blanchard, N. Giacomantonio +4 more
20212 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Rayson×24
Invite
D. Rayson — researcher profile on SciRah
C. Skedgel×19
Invite
C. Skedgel — researcher profile on SciRah
M. Sellon×6
Invite
M. Sellon — researcher profile on SciRah
R. Dewar×6
Invite
R. Dewar — researcher profile on SciRah

×5

Invite

A. Jeyakumar — researcher profile on SciRah

Invite

K. Virik — researcher profile on SciRah

N. Saint-Jacques×5

Invite

N. Saint-Jacques — researcher profile on SciRah

Invite

P. Barnes — researcher profile on SciRah

Invite

A. Drucker — researcher profile on SciRah

Invite

K. Thompson — researcher profile on SciRah

Invite

S. Snow — researcher profile on SciRah

K. Dakin-Hache×3

Invite

K. Dakin-Hache — researcher profile on SciRah